Dr Richard Booton, Consultant Respiratory Physician

Dr Richard Booton

Consultant Respiratory Physician

Book online
|

Dr Richard Booton MBChB, PhD, FRCP

Consultant Respiratory Physician

MBChB, PhD, FRCP

Dr Richard Booton

Consultant Respiratory Physician MBChB, PhD, FRCP

Book online
|
MBChB, PhD, FRCP
HCA-Healthcare-UK

Areas of expertise

  • Lung cancer
  • Thoracic oncological surgery
  • Clinical care in thoracic oncology
  • Advanced bronchoscopy
  • Asthma
HCA-Healthcare-UK

Address

  • HCA UK at The Wilmslow Hospital

    52-54 Alderley Road Wilmslow, London, SK9 1NY

  • The Christie Private Care

    Wilmslow Road, Manchester, M20 4BX

About Dr Richard Booton

GMC number: 3677320

Year qualified: 1992

Place of primary qualification: University of Leeds

Areas of expertise

  • Pre-malignancy
  • Lung cancer screening
  • Staging
  • Recurrent disease
  • Respiratory medicine
  • Thoracic oncology
  • Asthma
  • Chest Medicine
  • Lung Cancer
  • Lung disease
  • Respiratory pathology

Professional memberships

General Medical Council
British Thoracic Oncology Group
International Association for the Study of Lung Cancer

Articles by Dr Richard Booton

Yorkshire lung screening trial (ylst): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose ct screening for lung cancer versus usual care in a targeted population at risk

P1.05-029 sabrtooth-a feasibility study of sabr compared to surgery in patients with peripheral stage i nsclc considered to be at higher risk from surgery

Fc-optimized anti-cd25 depletes tumor-infiltrating regulatory t cells and synergizes with pd-1 blockade to eradicate established tumors

Analysis of lung cancer risk model (plco m2012 and llp v2 ) performance in a community-based lung cancer screening programme

Second round results from the manchester ‘lung health check’ community-based targeted lung cancer screening pilot

Endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in non-small cell lung cancer

“to know or not to know…?” push and pull in ever smokers lung screening uptake decision‐making intentions

Sequential screening for lung cancer in a high-risk group: randomised controlled trial

Allele-specific hla loss and immune escape in lung cancer evolution

Kras induces lung tumorigenesis through micrornas modulation